文献速递肾小球疾病

肾脏意义单克隆丙种球蛋白病的新视角

A Fresh Perspective on Monoclonal Gammopathies of Renal Significance.
PubMed 文献 · Kidney Int Rep · 2021-05-04

本文批判性分析了病理科、肾内科、血液科和免疫科实践中疑似MGRS的不同情况,重点讨论伴单克隆免疫球蛋白沉积的增殖性肾小球肾炎(PGNMID)这一组疾病,说明其MGRS状态认定的困难与模糊性,强调需证实致病性单克隆免疫球蛋白组织沉积的单克隆性质以指导治疗策略。

要点

  • MGRS涵盖多种由单克隆免疫球蛋白或其亚单位肾毒性导致的肾脏疾病。
  • 有效治疗依赖靶向可能存在的恶性B细胞克隆,但该克隆常为推测性。
  • PGNMID是MGRS状态认定困难与模糊的典型代表。

核心结论

  • 疑似MGRS的认定需有说服力地证实致病性单克隆免疫球蛋白组织沉积的单克隆性质,以设计合适治疗策略。

研究设计与样本

  • 本文为对疑似MGRS不同临床情境的批判性分析,聚焦PGNMID组疾病。

主要发现

  • MGRS涵盖多种由单克隆免疫球蛋白或其亚单位内在肾毒性导致的肾脏疾病。
  • 有效疾病修饰治疗依赖靶向恶性B细胞克隆,该克隆可能可证实但常为推测性。
  • PGNMID组疾病体现了MGRS状态确定性归属的困难与模糊性。

临床怎么用

  • 对疑似MGRS者需综合病理、肾内科、血液科和免疫科评估,重点证实组织沉积的单克隆性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monoclonal gammopathies of renal significance (MGRS) encompass a remarkable variety of kidney diseases that result from intrinsic nephrotoxic properties of certain monoclonal Igs or their subunits. Effective disease-modifying treatments rely on the targeting of a malignant B-cell clone that may be demonstrable but often is quite hypothetical. Hence, convincing arguments for the genuine monoclonal character of the causative mono-isotypic Ig tissue deposits is needed for design of appropriate treatment strategies. The purpose of this article was to critically analyze distinct situations of suspected MGRS that occur in the practice of pathologists, nephrologists, hematologists, and immunologists. A particular focus of interest is the group of conditions known as proliferative glomerulonephritis with mono-isotypic immunoglobulin deposits (PGNMIDs), which illustrates the difficulties and ambiguities surrounding a definitive assignment of MGRS status.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Aucouturier P, D'Agati VD, Ronco P, et al. A Fresh Perspective on Monoclonal Gammopathies of Renal Significance. Kidney Int Rep. 2021. PMID: 34386655. doi:10.1016/j.ekir.2021.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。